Research map: The Price of Precision: A Critical Review of Molecular Diagnostics in Glioma, From Guidelines to Global Disparities
Back to the article
Papers in this map
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary · David N. Louis · 2021 · 12624 citations · Cited by this paper
- Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis · 2026 · Related
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood · Michael Weller · 2020 · 2073 citations · Cited by this paper
- Comprehensive Molecular Genetic Analysis in Glioma Patients by Next Generation Sequencing · 2024 · Related
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective · Martin J. van den Bent · 2010 · 597 citations · Cited by this paper
- Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males · 2026 · Related
- The Lancet Commission on diagnostics: transforming access to diagnostics · Kenneth A Fleming · 2021 · 491 citations · Cited by this paper
- Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma · 2026 · Related
- Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system · Simon Gritsch · 2021 · 394 citations · Cited by this paper
- Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder · 2026 · Related
- Delivering precision oncology to patients with cancer · Joaquı́n Mateo · 2022 · 381 citations · Cited by this paper
- Evaluating the Cost of Genomic Testing for Biomarker-Driven Therapies in Oncology · 2026 · Related
- Epidemiology and Overview of Gliomas · Mary Elizabeth Davis · 2018 · 349 citations · Cited by this paper
- Communication between Caregivers of Adults with Cancer and Healthcare Professionals: a Review of Communication Experiences, Associated Factors, Outcomes, and Interventions · 2024 · Related
- The Pathobiology of Glioma Tumors · Candece L. Gladson · 2009 · 254 citations · Cited by this paper
- What’s new in neuropathology 2024: CNS WHO 5th edition updates · 2024 · Related
- Basic principles of biobanking: from biological samples to precision medicine for patients · Laura Annaratone · 2021 · 236 citations · Cited by this paper
- Management of Low-Grade Gliomas · 2025 · Related
- The European Society for Medical Oncology (ESMO) Precision Medicine Glossary · Lucy R. Yates · 2017 · 165 citations · Cited by this paper
- Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline · Felix Sahm · 2023 · 109 citations · Cited by this paper
- The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1—Key Points of the Fifth Edition and Summary of Imaging Findings on Adult‐Type Diffuse Gliomas · Yae Won Park · 2023 · 107 citations · Cited by this paper
- IDH inhibition in gliomas: from preclinical models to clinical trials · Roberta Rudà · 2024 · 97 citations · Cited by this paper
- Precision public health in the era of genomics and big data · Megan Clarke Roberts · 2024 · 92 citations · Cited by this paper
- MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme · Rosa Della Monica · 2022 · 60 citations · Cited by this paper
- MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives · Rajni Shaw · 2024 · 58 citations · Cited by this paper
- The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO · Young Zoon Kim · 2022 · 48 citations · Cited by this paper
- Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group · Susan S. Garfield · 2016 · 47 citations · Cited by this paper
- Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group · Herbert Ho-Fung Loong · 2023 · 43 citations · Cited by this paper
- Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country setting · Nyanda Elias Ntinginya · 2021 · 42 citations · Cited by this paper
- Classification and Diagnosis of Adult Glioma: A Scoping Review · Yoon Hwan Byun · 2022 · 42 citations · Cited by this paper
- Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors · Xiaopeng Guo · 2023 · 40 citations · Cited by this paper
- Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice · Aditi Puri Singh · 2020 · 39 citations · Cited by this paper
- Molecular diagnostics: techniques and recommendations for 1p/19q assessment · Adelheid Wöehrer · 2015 · 38 citations · Cited by this paper
- Diagnostic Errors, Health Disparities, and Artificial Intelligence · Said A. Ibrahim · 2021 · 37 citations · Cited by this paper
- Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area · Denis Horgan · 2023 · 36 citations · Cited by this paper
- Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics · Paulina Śledzińska · 2022 · 34 citations · Cited by this paper
- The 2021 WHO classification of central nervous system tumors: what neurologists need to know · Pouya Jamshidi · 2022 · 33 citations · Cited by this paper
- Barriers and facilitators to next-generation sequencing use in United States oncology settings: a systematic review · Andrea Ferreira‐Gonzalez · 2024 · 28 citations · Cited by this paper
- Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity · Katja Bender · 2023 · 28 citations · Cited by this paper
Source: OpenAlex (CC0)